Advancing Infection Control Through Smarter Antimicrobial Dressings

Preventing infection remains one of healthcare’s most important priorities. Despite advances in clinical protocols and infection-prevention practices, hospital-acquired infections continue to place a significant burden on patients, providers and healthcare systems. Intravenous lines, PICC lines and surgical incision sites are essential parts of patient care, but they can also create pathways for bacteria to enter the body. As concerns around drug-resistant organisms continue to grow, healthcare organizations are looking more closely at how they protect these vulnerable access points.

Today’s infection-control teams want more than a simple protective covering.

For years, hospitals have relied on skin-preparation solutions and traditional dressings as part of standard infection-prevention protocols. While these approaches remain important, clinicians increasingly recognize that protection cannot stop once a catheter is placed or a procedure is completed. Bacteria can return to the skin surface, and microorganisms may persist around insertion sites even after careful preparation. This has led healthcare providers to seek antimicrobial dressings that continue working long after the initial procedure is over.

The focus of discussion has changed from preventing infection to actively preventing infection. Leaders in health care facilities are starting to look at how well the dressing will assist in the control of microbes over time, not just how well it protects the wound initially, but what kind of healing environment it provides for the entire time that the dressing is on the wound. This is particularly important for long-term vascular access devices and for other patients at increased risk of infection.

The way an antimicrobial agent is delivered has become a major point of differentiation. Clinicians are paying closer attention to whether a dressing can provide sustained antimicrobial activity while remaining gentle on the skin. This balance is important because patients often require dressings for days or even weeks, and irritation can lead to discomfort, reduced adherence or the need for additional interventions.

It is well known that the risk of infection does not begin and end at the surface of the skin. Bacteria can remain in hair follicles and at insertion sites even after disinfection, therefore, continuing antimicrobial therapy is crucial to prevent infections. This is leading to a hospital trend in which, rather than the simple preparation of the skin before insertion, healthcare facilities are actively seeking a dressing that works throughout the therapy. A key feature of the desired product type is that, in addition to protecting the insertion site, it provides effective and consistent performance. Reliable performance day in, day out is a primary concern for clinicians, and infection-control benefits depend on how long an antimicrobial remains active without complicating clinical practice.

Prevahex has generated significant interest due to its method of delivering chlorhexidine. Its product uses a pure form of the active ingredient, embedded in a patent-pending polymer, which releases the drug as an effective antimicrobial agent at the insertion site within a clear, self-adherent dressing. The technology behind the product relies on a non-thermal manufacturing technique to preserve the full efficacy of the active agent while ensuring patient comfort. It is the 1491 Securement Dressing that the product uses for any IV starts and PICC and catheter securement procedures, as well as in higher-risk applications such as ECMO and surgery. By combining sustained activity with clinical usability, Prevahex offers facilities an extra layer of defense against infection.